4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000017
PRESIDENT AND COO sold 22,500 shares at an average $514.35 ($11,572,963)
- PRESIDENT AND COO acquired 14,625 shares (option exercise)
- PRESIDENT AND COO acquired 7,875 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENKOWITZ MICHAEL · PRESIDENT AND COO
Table I: Non-derivative
17 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-22 | Exercise or conversion : show line 1 in the form 10b5-1 | −14,625 | $117.76 | $1,722,240 | 14,625 | I |
| 2025-12-22 | Sale : show line 2 in the form 10b5-1 | −682 | $512.14 | $349,278 | 13,943 | I |
| 2025-12-22 | Sale : show line 3 in the form 10b5-1 | −848 | $513.40 | $435,363 | 13,095 | I |
| 2025-12-22 | Sale : show line 4 in the form 10b5-1 | −11,815 | $514.31 | $6,076,534 | 1,280 | I |
| 2025-12-22 | Sale : show line 5 in the form 10b5-1 | −440 | $515.53 | $226,834 | 840 | I |
| 2025-12-22 | Sale : show line 6 in the form 10b5-1 | −560 | $516.37 | $289,166 | 280 | I |
| 2025-12-22 | Sale : show line 7 in the form 10b5-1 | −200 | $517.74 | $103,548 | 80 | I |
| 2025-12-22 | Sale : show line 8 in the form 10b5-1 | −80 | $518.91 | $41,513 | 0 | I |
| Open-market sales · 22,500 sh · avg $514.35 · $11,572,963 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-22 | Exercise or conversion : show line 18 in the form 10b5-1 Stock Options | −6,190 | 0 | I |
| 2025-12-22 | Exercise or conversion : show line 19 in the form 10b5-1 Stock Options | −1,685 | 68,065 | I |
| 2025-12-22 | Exercise or conversion : show line 20 in the form 10b5-1 Stock Options | −14,625 | 126,375 | I |
Loading xslF345X05/primarydocument.xml…